Showing results (1091-1100 of 1,216) with videos related to
Sort By:
Pageof 122
Arthritis Research & Therapy|October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyMichele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.Pain Medicine (Malden, Mass.)|July 11, 2026
Sociodemographic Factors, but Not Rurality, Explain Limited Variance in Fibromyalgia Severity: A Secondary Analysis of Two Randomized Clinical TrialsEzgi Yarasir Gillette, Kari G Vance, Emine O Bayman, et al.European Journal of Dermatology : EJD|January 10, 2018
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinicsMaria Concetta Fargnoli, Gianfranco Altomare, Elisa Benati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2006
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, et al.Tumori|February 24, 2001
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot studyG Ferrara, G Argenziano, H P Soyer, et al.Journal of Clinical and Translational Science|September 22, 2025
Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trialKari G Vance, Jonah Pedelty, Barbara J Van Gorp, et al.Autophagy|November 5, 2019
Pharmacological restoration of autophagy reduces hypertension-related stroke occurrenceMaurizio Forte, Franca Bianchi, Maria Cotugno, et al.The Journal of Allergy and Clinical Immunology|June 10, 2014
Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasisElisabetta Volpe, Lucia Pattarini, Carolina Martinez-Cingolani, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2006
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensusW-H Boehncke, R A Brasie, J Barker, et al.Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life studyRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.Pageof 122